» Articles » PMID: 30230244

Effects of Chronic NAD Supplementation on Energy Metabolism and Diurnal Rhythm in Obese Mice

Overview
Date 2018 Sep 20
PMID 30230244
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Adequate nicotinamide adenine dinucleotide (NAD) content in hypothalamic neurons is critical for the maintenance of normal energy balance and circadian rhythm. In this study, the beneficial metabolic effects of chronic NAD supplementation on diet-induced obesity and obesity-related disruption of diurnal rhythms were examined.

Methods: C57BL/6 mice were fed a high-fat diet (HFD) for 12 weeks and received an intraperitoneal injection of either saline or NAD (1 mg/kg/day) for the last 4 weeks. The control mice were fed a chow diet and injected with saline for the same period. Body weights were monitored daily. Daily rhythms of food intake, energy expenditure, and locomotor activity were measured at the end of NAD treatment. The effect of NAD treatment on the clock gene Period 1 (PER1) transcription was also studied.

Results: Chronic NAD supplementation significantly attenuated weight gain in HFD-fed obese mice. Furthermore, NAD treatment recovered the suppressed rhythms in the diurnal locomotor activity patterns in obese mice. In addition, exogenous NAD supply rescued cellular NAD depletion-induced suppression of PER1 transcriptional activity in hypothalamic neuron cells as well as blunted daily fluctuations of hypothalamic arcuate nucleus PER1 expression in obese mice.

Conclusions: NAD supplementation showed therapeutic effects in obese mice with altered diurnal behaviors.

Citing Articles

Changes in glucose metabolism, C-reactive protein, and liver enzymes following intake of NAD + precursor supplementation: a systematic review and meta-regression analysis.

Sohouli M, Tavakoli S, Reis M, Hekmatdoost A, Guimaraes N Nutr Metab (Lond). 2024; 21(1):35.

PMID: 38915015 PMC: 11195006. DOI: 10.1186/s12986-024-00812-0.


Hepatic steatosis induced by nicotine plus Coca-Cola™ is prevented by nicotinamide riboside (NR).

Rivera J, Espinoza-Derout J, Hasan K, Molina-Mancio J, Martinez J, Lao C Front Endocrinol (Lausanne). 2024; 15:1282231.

PMID: 38756999 PMC: 11097688. DOI: 10.3389/fendo.2024.1282231.


Effects of psychogenic stress on oxidative stress and antioxidant capacity at different growth stages of rats: Experimental study.

Lee S, Itagaki A, Satoh A, Sugimoto I, Saito T, Shibukawa Y PLoS One. 2024; 19(4):e0287421.

PMID: 38653001 PMC: 11038576. DOI: 10.1371/journal.pone.0287421.


NAD-A Hub of Energy Metabolism in Heart Failure.

Wu Y, Pei Z, Qu P Int J Med Sci. 2024; 21(2):369-375.

PMID: 38169534 PMC: 10758143. DOI: 10.7150/ijms.89370.


The effects of NAD+ precursor (nicotinic acid and nicotinamide) supplementation on weight loss and related hormones: a systematic review and meta-regression analysis of randomized controlled trials.

Baichuan Y, Reis M, Tavakoli S, Khodadadi N, Sohouli M, Guimaraes N Front Nutr. 2023; 10:1208734.

PMID: 37854354 PMC: 10579603. DOI: 10.3389/fnut.2023.1208734.